[Corrections] Correction to Lancet Oncol 2023; 24: e242

Venkatesan P. New US breast cancer screening recommendations. Lancet Oncol 2023; 24: e242—In this News piece, the first sentence of the second paragraph should have read “The USPSTF’s previously recommended biennial screening for all women aged 50–74 years, with those aged 40–50 years encouraged to make a decision with their physician” and the first sentence of the third paragraph should have read “Two major factors underpinned the decision to expand the recommended starting age for screening all women from 50 to 40 years”.